Information from the Pharmaceutical Services Unit (PSU) The PDL Professional Officers often receive enquiries relating to the validity of psychostimulant prescriptions written for NSW patients.
New opportunities and changes continue for Queensland pharmacists, and PDL would like to remind Qld-based members of these changes for the benefit of patients and
Understanding the click method PDL has become aware of a number of adverse events and health consequences from the popularised method of OZEMPIC® (semaglutide) administration
From 1 July 2024, pharmacists in Tasmania can offer resupply of the oral contraceptive pill (OCP) without a doctor’s prescription to individuals who meet specific
The UTI component of the NSW Pharmacy Trial ceased on 31 May 2024. From 1 June 2024, NSW pharmacists holding general registration, who have completed
When pharmacists receive regulatory notifications, a range of common misconceptions can cloud their perception and impede their ability to respond effectively. Among these misconceptions are
From 28 May 2024, pharmacists in Western Australia can supply women who meet certain criteria with a resupply of the oral contraceptive pill (OCP) without
Social media has become part of everyday life for many people including pharmacists. It can also be harnessed by pharmacy businesses to improve engagement with
From 6 May 2024, pharmacists in South Australia can provide women who meet certain criteria with a resupply of the oral contraceptive pill (OCP) without
The safety of a pharmacist’s patients should always be front of mind. Beyond a pharmacist’s clinical expertise, the culture within our healthcare settings significantly impacts
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.